Atlas Trials

Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors (Phase 2)

Clinical trial NCT04790708 · UNKNOWN

Trial details

NCT number
NCT04790708
Sponsor
University Hospital of Ferrara
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Neuroendocrine TumorsPeptide Receptor Radionuclide Therapy (PRRT)
Start date
2018-07-02
Primary completion
2023-06-30
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.